Abstract
The outbreak of swine flu is highlighting the public health importance of
improved testing techniques and providing market opportunities for
manufacturers of diagnostic tests and other products related to the disease.
These conclusions and others appear in a new report released from Kalorama
Information: Swine Flu Market Alert by Kalorama' s lead analyst, Shara Rosen.
Regardless of the eventual severity of the epidemic, there will be distinct
market impact on both immunoassay and molecular test makers, according to the
report. The makers of certain tests will benefit both in terms of sales and
more broadly in recognition that their products play a vital role in making
the public health community significantly better prepared for this possible
pandemic than 1968 or before.
The report examines:
- Market Impact likely for immunoassays and molecular testing.
- Lessons from previous epidemics, likely impact on both immunoassays and
molecular testing.
- Overview of the H1N1 strain as compared to other.
- Immunoassay and Molecular Test Products Available on the Market
- Developments in the last few days of significance to the diagnostic
industry.
- Profiles of nearly 25 specific manufacturers active in this space.
The report focuses almost exclusively on the in vitro diagnostic industry as
it applies to work being done by commercial entities and products that are
either in development or have been brought to market.
The market assessment provided has been assembled based on publicly available
information. Company sales data and other quantitative evaluations of the
markets for flu diagnostics have been developed based on publicly available
information and are expressed in US dollars, no adjustments have been made for
currency exchange fluctuations.
Under normal circumstances, a report of this genre would be assembled from
information derived from primary and secondary sources. However, in the short
time it took to research and write this report, almost all of the major
scientific and industry experts were occupied with the extraordinary task of
preparing for a pandemic.
Therefore the information contained in this report has been assembled from a
vast array of scientific and market publications, government sources, analyzed
by a professional analyst.
|